Volume 99, Issue S1 pp. 1482-1489
ORIGINAL STUDIES

Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study

Qifeng Zhu MD

Qifeng Zhu MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Zhengdu Yuan MD

Zhengdu Yuan MD

Department of Cardiology, Taizhou Municipal Hospital, Taizhou, China

Search for more papers by this author
Yeming Xu MD

Yeming Xu MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

School of Medicine, Zhejiang University, Hangzhou, China

Search for more papers by this author
Jun Chen MD

Jun Chen MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

School of Medicine, Zhejiang University, Hangzhou, China

Search for more papers by this author
Stella Ng MD

Stella Ng MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

School of Medicine, Zhejiang University, Hangzhou, China

Search for more papers by this author
Abuduwufuer Yidilisi MD

Abuduwufuer Yidilisi MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

School of Medicine, Zhejiang University, Hangzhou, China

Search for more papers by this author
Kaida Ren MD

Kaida Ren MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Yuwen Chen MD

Yuwen Chen MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Wangxing Hu MD, PhD

Wangxing Hu MD, PhD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Gangjie Zhu MD

Gangjie Zhu MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Feng Liu MD

Feng Liu MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

School of Medicine, Zhejiang University, Hangzhou, China

Search for more papers by this author
Mengqiu Dang MD, PhD

Mengqiu Dang MD, PhD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Yuxin He MD

Yuxin He MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Yuchao Guo MD

Yuchao Guo MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Jiaqi Fan MD

Jiaqi Fan MD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
Xianbao Liu MD, PhD

Corresponding Author

Xianbao Liu MD, PhD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Correspondence Xianbao Liu, MD, PhD, Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Jiefang Rd No. 88, 310009 Hangzhou, China. 

Email: [email protected]

Search for more papers by this author
Jian'an Wang MD, PhD

Jian'an Wang MD, PhD

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Search for more papers by this author
First published: 24 March 2022
Citations: 5

Qifeng Zhu and Zhengdu Yuan contributed equally to this study.

Abstract

Objectives

We aimed to validate a novel staging system for aortic stenosis (AS) in a Chinese patient cohort undergoing transcatheter aortic valve replacement (TAVR), and to compare this classification system to the traditional Society of Thoracic Surgeons (STS) score for TAVR risk stratification.

Background

A novel staging system for AS based on the extent of cardiac damage upon echocardiography was recently proposed.

Methods

Patients were prospectively enrolled into the Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population and analyzed retrospectively following additional exclusion criteria. On the basis of echocardiographic findings of cardiac damage, patients were classified into five stages (0–4).

Results

A total of 427 patients were included in the current analysis. Forty-eight deaths occurred during a median follow-up of 730 days following TAVR. The staging system showed a statistically significant association between cardiac damage and all-cause mortality; advanced stages were associated with higher mortality. In a multivariate-adjusted Cox proportional hazards regression model, stage and STS scores served as risk factors for 2-year mortality. Each increment in the staging class was associated with an increased risk of mortality (hazard ratio, 1.275; 95% confidence interval [CI], 1.052–1.545). Receiver operating characteristic (ROC) curves were plotted for stage (area under the curve, 0.644; 95% CI, 0.562–0.725) and STS score (0.661; 0.573–0.749), and with no statistically significant differences between ROC curves (p = 0.920).

Conclusions

We validated a novel staging system as a key risk factor for 2-year mortality in a Chinese TAVR patient cohort. Efficacy for risk stratification was comparable to the STS score.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data used for this study, though not available in a public repository, will be made available upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.